LW140 Investigational Medicinal Product (IMP) Support – TOCSINS

The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams. The trial will be running in Brazil and Ghana and involves two oral medications. Initial dose will be delivered to remote community clinic or ambulance vehicle (field) and subsequent doses stored and given from the hospital site during the participant admission. To view this notice, please click here...